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ABSTRACT 
 
Objective Our aim was to investigate the geospatial distribution of diabetic foot disease in 
small geographical areas with varying levels of multiple deprivation. 
Research Design and Methods We undertook a population cohort study to extract the health 
records of 112,231 people with diabetes from the Scottish Care Information – Diabetes 
Collaboration (SCI-diabetes) database. We linked this to health records to identify death, LEA 
and DFU outcome events. These events were geospatially mapped using multiple deprivation 
maps for the geographical area of NHS Greater Glasgow and Clyde. Tests of spatial 
autocorrelation and association were conducted to evaluate geographical variation and 
patterning, and the association between prevalence-adjusted outcomes and multiple deprivation 
by quintile.   
Results Within our health board region, people with diabetes had crude prevalence-adjusted 
rates for DFU of 4·6%, for LEA of 1·3% and an incidence rate of mortality preceded by either 
a DFU or LEA of 10·5 per 10,000 per year. Spatial autocorrelation identified statistically 
significant hot spot (high prevalence) and cold (low prevalence) clusters for all outcomes. 
Small-area maps effectively displayed near neighbour clustering across the health board 
geography. Disproportionately high numbers of hot spots within the most deprived quintile for 
DFU (P<0·001), LEA (P<0·001) and mortality (P<0·001) were found. Conversely, a 
disproportionately higher number of cold spots was found within the least deprived quintile for 
LEA (P<0·001). 
Conclusions In people with diabetes, DFU, LEA and mortality are associated with multiple 
deprivation and form geographical neighbourhood clusters.  
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RESEARCH IN CONTEXT 
What is already known about the subject? 
1. Regional variation but no spatial correlation in death following foot ulceration was 
reported in a large UK general practice study. A second UK study containing people 
with and without diabetes identified regional variation in lower extremity amputation 
rates but no association with social deprivation. Two US studies identified national and 
state-specific variations in lower extremity amputation, this variation was associated 
with socioeconomic status.  
2. Measurement of exposure to deprivation varies across studied to include single 
indicators such as household income, multiple deprivation indices such as the 
Townsend index, or not included at all. Geographic unit of analyses varied from UK 
strategic health board and major regions to US hospital referral regions for all states or 
Zip Code Tabulation Areas.  
3. There were no studies that simultaneously investigated foot ulceration, lower extremity 
amputation and mortality outcomes. 
Key question 
Does multiple deprivation influence geospatial variance in major diabetic foot disease 
outcomes? 
New findings 
1. Data linkage and small area geospatial mapping techniques providing almost complete 
population coverage and granular capture of multiple deprivation exposure not found 
in other studies.  
2. We found strong geographical patterning of all three outcomes with clustering of high 
prevalence-adjusted outcomes in the areas of highest deprivation and low prevalence-
adjusted outcomes in areas of least deprivation. 
3. This work identified major inequalities in outcomes for diabetic foot disease, associated 
with multiple deprivation not previously reported.  
How might this impact on clinical practice in the foreseeable future?  
Variation in outcomes of diabetic foot disease by geographical location within health 
administration regions should be more widely recognised. High prevalence should be 
anticipated in areas exposed to the greatest multiple deprivation. These finding can help guide 
how future diabetes foot health services might be planned, organised and resourced.  
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INTRODUCTION 
Diabetic foot ulcers are a devastating, disabling and costly complication of diabetes with a 
lifetime incidence between 19-34% [1]. Amputation-free survival rates are lower in patients 
with healed or active ulcer history [2]. Further, mortality rates are high following LEA, 
reportedly 44% at 1 year, 57% at 3 years and 77% at 5 years [3]. There are complex pathways 
leading to diabetic foot disease and relative exposure to social deprivation is a potential risk 
factor [4-7]. With respect to LEA, exposure to deprivation together with high comorbidity 
burden, ethnicity, male gender and past history of DFU and LEA are strongly associated with 
increased risk [4]. Moreover, social deprivation increases the mortality burden in people with 
diabetes who develop a DFU: 14% per quintile of deprivation as reported by Anderson et al 
(2017) [8]. 
The role of deprivation exposure includes delays in seeking health assessment, financial 
pressures to maintain income and avoid cost of care, inappropriate advice, limited access to 
primary care advice and expertise, self-care, nutrition and footwear [6, 7]. However, this 
remains controversial when studied by geographical location. In UK cities with high levels of 
deprivation, socioeconomic status emerged as an independent predictor for developing DFU 
[6]. Conversely, other UK studies have found no increase in relative risk of DFU for 
socioeconomic status and once a DFU occurs, the effect of social deprivation exposure appears 
to be less influential with respect to independently predicting ulcer wound healing [9-12].  
Relative exposure to social deprivation may be one factor that explains geographical variations 
in outcome events for diabetic foot disease [7]. For example, geographical variation has been 
demonstrated for rates of LEA in people with diabetes across NHS England at region, health 
authority and primary care trust level [13-15]. However, exposure to social deprivation could 
not explain these variations. This may be attributed to the large geographical areas studied 
comprising large populations and heterogeneity of levels of deprivation within each area. By 
contrast, in a US Medicare population, clustering of high incidence rates of LEA have been 
found in regions with lower socioeconomic status [16]. A more granular analysis identified a 
ten-fold variation and geographical clustering in amputation rates between high income and 
low income and urban and rural regions of California [17]. Moreover, Bergin et al (2011) 
identified higher numbers of Australian state-level hospital-based episodes of care for diabetes 
related foot disease in local government areas with the highest socio-economic disadvantage 
[18]. However, geographical factors associated with accessibility to general practitioners or 
hospital clinics were not found to be associated with DFU or LEA in a large UK cohort study 
[6].  
Thus far the patterning of deprivation and its association with diabetic foot disease morbidity 
and mortality have not been fully investigated. Across studies, exposure to deprivation was 
measured by a single indicator - household income, multiple deprivation indices, or not 
included. Geographic unit of analyses varied from UK strategic health board and major regions 
to US hospital referral regions for all states or Zip Code Tabulation Areas for the state of 
California. These geographic areas comprised inhabitant numbers of 3,000 or higher. There 
were no studies that simultaneously investigated foot ulceration, lower extremity amputation 
and mortality outcomes. Therefore, in this study we used a data linkage and geospatial mapping 
approach, to investigate geographical variation of diabetic foot disease in Glasgow, UK – a city 
with high dispersion of social inequality [19].  
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RESEARCH DESIGN AND METHODS 
Data sources: 
We conducted a retrospective population cohort and geospatial mapping study within the 
National Health Service (NHS) administrative area of Greater Glasgow and Clyde. Local and 
national health datasets were linked at the individual patient level using a unique patient 
identifier - the Community Health Index (CHI). Data linkage was undertaken by NHS Greater 
Glasgow and Clyde Safe Haven. Following linkage, the CHI number was removed to 
anonymise information and databases presented to researchers through a secure analysis 
platform (ESM figure 1).  
The Scottish Care Information – Diabetes Collaboration (SCI-Diabetes) is a national 
population database containing demographic and clinical data from a fully integrated electronic 
patient record. This was linked to the national hospital admissions data (Scottish Morbidity 
Record SMR01) and the National Records of Scotland (NRS) data. We obtained peer review, 
Safe Haven review, Local Privacy Advisory Committee and Caldicott Guardian approvals for 
the study (reference: GSH/16/DI/002).  
Study Population: 
Data extraction was undertaken in November 2016. We included all people in the SCI-Diabetes 
database registered within NHS Greater Glasgow and Clyde from 01/01/2002. This health 
administration area comprises six local authorities with a population of 1,169,110 (21·6% of 
the Scottish population). 
Data Variables: 
From SCI-Diabetes we described the population cohort by ascertaining age, gender, diabetes 
type, disease duration, and ethnicity. Diagnosis of diabetes was based on practice systems 
(read-codes) and SCI-Diabetes diagnostic information webforms. DFU outcome was extracted 
from SCI-Diabetes data items based on the foot risk stratification described by Scottish 
Intercollegiate Guideline Network (SIGN) guideline 116 criteria for previous or active ulcer 
on right and left foot [20]. From SMR01 we extracted LEA outcomes using the Office of 
Population Censuses and Surveys (OPCS) classification of interventions and procedures 
coding. We combined codes for major (above the ankle joint [OPCS codes X09, X10]) and 
minor amputations (OPCS codes X10, X11) for right and left sides [21]. Mortality data was 
extracted from the NRS database. Exposure to social deprivation was by 2016 SIMD score 
[22]. SIMD identifies small area concentrations of multiple deprivation using 38 indicators 
across seven domains (employment, income, crime, housing, health, education and access). 
Deprivation scores are ranked highest to lowest for 6976 areas or data zones across Scotland 
each with a median population of 760. NHS Greater Glasgow and Clyde comprised 1,460 data 
zones and we expressed scores by quintiles, with one representing the 20% most deprived and 
five representing the 20% least deprived areas (ESM Figure 2). Each person with diabetes was 
assigned a data zone during data linkage using the most recent census and postcode information 
from the NRS record. 
 
Statistical Analysis: 
We describe the study population and its demographic and clinical characteristics using mean, 
standard deviation, absolute values and percentages. Maps were generated to visually present 
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the spatial distribution of diabetic foot outcomes across the health board data zones. This was 
undertaken using ArcGIS 10.4 Geostatistical Analyst (ESRI, Redlands, CA, USA). The 
geographic unit of analysis was the SIMD data zones determined from Scottish Government 
2016 SIMD map [22] (ESM Figure 2). Participants data zone number was extracted and linked 
to health records matching the shape file for the 2016 SIMD map (ESM Figure 1). Since the 
total population of people with diabetes for each data zone was known, the crude prevalence-
adjusted rates for DFU, LEA and incidence rates for death preceded by a DFU or LEA were 
calculated. Complete geographical coverage of LEA and mortality data was reliable since this 
was extracted from SMR01 and NRS sources and therefore analysed between 2002-2016. SCI-
Diabetes was implemented in NHS Greater Glasgow and Clyde in 2002 with screening tools 
for diabetic foot disease added later and progressively rolled out over the board.  We therefore 
estimated that complete geographical coverage of DFU data could be reliably determined 
towards the end of 2011. Therefore, DFU prevalence-adjusted rates were estimated from a subset of 
the cohort for the period 01/01/2012 – 07/11/2016 
We explored spatial clustering at the small-area data zone level (comprising on average 760 
people), specifically that diabetic foot outcome events would be correlated at nearer locations 
with similar social deprivation than outcomes at locations further apart. A data zone with a 
high prevalence of DFU, LEA or mortality surrounded by data zones with high values may be 
a statistically significant hot spot. Each data zone adjusted prevalence is compared 
proportionately to the prevalence rates for the entire health board area. If the observed data 
zone prevalence is very different from the expected data zone prevalence, and is too large to 
be random, is it a statistically significant hot spot (or conversely a cold spot). We conducted 
spatial autocorrelation using Getis-ord Gi* [23]. The GI* statistic is a Z-score and assumed to 
be normally distributed. Clusters with a 90% or higher significance level from a two-tailed 
distribution indicate significant clustering of data zones. In designing the spatial model, firstly 
we conceptualised the spatial relationship parameter, in that data zone polygons were of 
differing dimensions (larger towards the periphery representing more rural data zones and 
smaller heading centrally, more urban). Consequently, we utilised a theoretical fixed distance 
band technique to counterbalance this. Secondly, we corrected the model for polygons with 
shared boundaries. Here contiguity edges and corners were selected in the spatial model 
ensuring that data zones with a shared edge or a corner were treated as neighbours and entered 
separately for each calculation in the hot spot analysis. Thirdly, the Gi* Z value was displayed 
through colour codes (red = hot spots and blue = cold spots) across the SIMD maps. The 
distribution of hot and cold spots across SIMD quintiles was analysed separately using a one-
sample Chi-square test. These analyses were conducted using IBM SPSS statistics 23 
(IBM Corp, Armonk, NY, USA). A p value <0.05 was considered significant.   
RESULTS 
We extracted and linked the records of 112, 231 people from SCI-Diabetes between 2002 and 
2016. The average age of the population cohort was 67·2 years (SD 15·4 years), 53% were 
male, 65·1% were of white Scottish/British ethnicity, and 75·2% had type 2 diabetes (Tables 
1 and 2). Overall, 41·5% of patients were in the most deprived and 13·8% in the least deprived 
quintiles.  
From 2012-2016, the denominator changed to 85,667 individuals registered on SCI Diabetes 
during this time period. One or more DFU was identified in 3,923 patients with a crude 
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prevalence-adjusted rate of 4·6% (Table 1). Between 2002-2016, LEA was identified in 1,507 
(1·3%) patients and 1,643 (an incidence rate of 1·5 per 10 000 per year) with a past history of 
DFU or LEA had died (Table 2).  We identified a significantly higher proportion of patients 
for each outcome in SIMD quintile 1 for DFU (Χ2(4) 1429, P <0·001), LEA (Χ2(4) 825, P 
<0·001), and mortality preceded by DFU or LEA (Χ2(4) 786.0, P<0·001) (Figure 1).  
Spatial autocorrelation identified statistically significant hot spot (high prevalence) and cold 
spot (low prevalence) clusters for DFU (2012-2016), LEA and mortality (2002-2016) (Figure 
2). In total we identified 129 (8·8% of total 1460 data zones) hot spots and 84 (7·8%) cold spot 
data zones for DFU; 118 (8·1%) hot spots and 61 (4·2%) cold spot data zones for LEA; 117 
(8.0%) hot spots and 33 (2.3%) cold spot data zones for mortality preceded by a DFU; and 108 
(7.4%) hot spots and 14 (1·0%) cold spot data zones for mortality preceded by a LEA. Figure 
2 provides a visual appreciation of clustering across the health board data zones. Neighbouring 
data zones show similarly high or low prevalence rates for all three outcomes and all diabetes. 
We found contiguous clustering of high prevalence data zones along the estuary of the River 
Clyde and in the east end of the city as well as the north-eastern local authority area. We found 
fewer cold spots but evidence of contiguous clustering of areas immediately bordering the north 
bank of the River Clyde and suburbs immediately to the north and south of Glasgow city centre. 
We identified a disproportionately high number of hot spots within SIMD quintile 1 (most 
deprived) for DFU (Χ2(4) 79·6, P<0·001), LEA (Χ2(4) 101·2, P<0·001), mortality preceded by 
DFU (Χ2(4) 26.4, P<0·001), and mortality preceded by a LEA (Χ2(4) 26.4, P<0·001). Although 
there were more cold spots forming in SIMD quintile 5 (least deprived) for each outcome, the 
trend was not statistically significant for DFU (Χ2 8·6, P=0·071), mortality preceded by DFU 
(Χ2(4) 2·3, P=0·680), and mortality preceded by a LEA (Χ2(4) 8.1, P=0·086), but it was 
significant for LEA (Χ2(4) 22·5, P<0·001) (Figure 3).  
 
DISCUSSION 
Principle Findings: 
We found a four-to-fivefold difference in the crude prevalence-adjusted rates of people with 
diabetes with DFU, LEA and mortality outcomes between the most and least deprived areas 
within NHS Greater Glasgow and Clyde. For DFU over half the hot spot clusters were found 
in the most deprived areas with the remaining evenly distributed across quintiles 2-5. For LEA, 
three-quarters of the hot spots were distributed between the two most deprived quintiles with 
10 percent or fewer observed for SIMD quintiles 3-5. Similarly, death preceded by either a 
DFU or LEA was disproportionately observed in the two most deprived quintiles (66% and 
62% respectively). This health board comprised around one-fifth of the Scottish population. 
Our small-area geography maps effectively display and communicate these findings with 
sufficient granularity to detect near neighbour clustering. Relative exposure to deprivation does 
not prevent DFU, LEA or associated mortality as we identified hot and cold spot clusters across 
all deprivation quintiles. Cold spots were equally distributed across all levels of deprivation for 
DFU and mortality but observed less often in the least deprived areas for LEA. The reasons for 
this are unclear although around 80% of LEA are preceded by a DFU so less deprived areas 
might afford better secondary prevention and access to expert foot healthcare.  
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We have identified for the first time that neighbourhoods with poor outcomes related to diabetic 
foot disease are surrounded by a concentration of other areas with similar poor outcome in the 
most socially deprived areas. This was noticeable along the Clyde estuary, Inverclyde and the 
east end of Glasgow City Centre which, following deindustrialisation, has neighbourhoods 
within the top 5% of all deprived areas in Scotland. Such concentrations may serve to deepen 
poor health behaviours and culture and provide few resources to be drawn on, the so called 
‘pull-down’ effect [24]. Conversely, but to a much lesser extent, we have identified lower than 
anticipated prevalent outcome in local concentrations in the least deprived areas of the health 
board for LEA, the so called ‘pull-up’ effect. We also found that local areas within SIMD 
quintile 1 (most deprived) had prevalent outcome rates similar to neighbourhoods with less 
deprivation. These deprived areas might draw on nearby diabetic foot services and other health 
resources. Further, people with diabetes might experience less social detachment and better 
behaviours such as self-esteem and resilience in these neighbourhoods but this requires further 
investigation [19].  
 
Consistency with previous research: 
Regional variations in DFU and LEA rates have been previously reported but the association 
with social deprivation is controversial [13-16]. Our work confirms the association of ‘hotspot’ 
geographical patterning of LEA and socioeconomic deprivation and extends these findings to 
include DFU and mortality [17]. We employed SIMD which captures a wider set of deprivation 
determinants including education, crime, housing, and health that builds in comorbidities, 
alcohol, and drug misuse. Accordingly, SIMD is not directly comparable with other deprivation 
indices and when applied to small geographical areas might partly explain why other studies 
have not found a relationship. Nevertheless, it is possible to conceptualise how these domains 
can impact on diabetic foot disease and its management. For example, non-attendance at 
general practice is highest in those in the most deprived areas of Scotland [25]. In people with 
diabetes, this could lead to unmet foot health needs including regular assessment of risk status 
and management strategies to prevent DFU. Using small-area maps to visualise diabetic foot 
outcomes at a local level is novel and follows work for type 2 diabetes risk in London [26]. 
Strengths and Limitations: 
The strength of the study lies in targeting Glasgow as a setting for three reasons, (1) poor health 
outcomes are generally concentrated in West Central Scotland, in particular the Glasgow 
conurbation which is exposed to deindustrialisation and deprivation [27], (2) major inequalities 
for diabetes incidence and mortality by socioeconomic status have been reported in Scotland, 
including Glasgow [28,29], and (3) DFU and LEA are highly prevalent in the Glasgow health 
board region [29]. Additionally, we used SIMD in local areas with similar deprivation 
characteristics. This beneficially limits heterogeneity in deprivation exposure and provides 
fine-grained geographical variability at local levels. There are a number of limitations. Firstly, 
the use of crude rates of DFU, LEA and mortality are important for geospatial mapping to 
identify hot and cold spots. However, association with social deprivation may be confounded 
by other factors such as age and gender and future explanatory analyses should make 
adjustments where indicated. Secondly, the study was conducted in one Scottish Health Board 
and may not be generalizable beyond that population. However, Glasgow’s unique SIMD 
patterning also provides an ideal testbed to assess the outcomes of diabetic foot disease in a 
region with high levels of deprivation, encompassing almost one fifth of the Scottish population 
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[19]. Ethnicity overlaps with poverty, deprivation and restricted access to health care [30]. 
Since key ethnic minority groups live in socioeconomically disadvantaged circumstances in 
the UK this may have contributed to the geospatial patterns observed. We are unable to account 
for this with current geospatial mapping approaches. However, this is not straightforward 
because in Glasgow proportionately much higher key ethnics minority groups including 
Chinese, Indian and Pakistani, live in much less socioeconomically disadvantaged 
circumstances [30]. Thirdly, SCI-Diabetes captures routine clinical data that may vary in 
completeness and accuracy across locations and practices. Despite this, SCI-diabetes is a 
validated clinical registry which captures 99% of individuals who have a diagnosis of diabetes 
within the NHS Greater Glasgow and Clyde, enabling population-level analysis [31]. Fourthly, 
for each person with diabetes, we extracted DFU, LEA and mortality data over a 14-year period 
from SCI Diabetes and other datasets linked to their most recent data zone. Although data zones 
are constructed to represent natural communities and physical boundaries with stable and 
reasonably consistent population size we are unable to account potential misallocation of an 
outcome event to another previous data zone if a person moved.  Neither were we able to 
account for DFU prior to 2012, changes over time related to disease natural history or local 
variation in implementation and adoption of foot screening programmes and treatment 
pathways. Finally, although the results indicate an association between SIMD and the event 
outcome, due to the observational nature of this study, we cannot exclude reverse causality to 
explain these findings i.e. having a DFU or LEA results in increased exposure to deprivation 
rather than being a consequence of it.  
 
Summary: 
In conclusion, we successfully employed small-area geospatial mapping to reveal important 
inequalities in diabetic foot outcomes which are associated with multiple deprivation. There 
was a four-to-fivefold variation in outcomes for DFU, LEA and mortality from the most-to-
least deprived neighbourhoods.  
Future Research: 
We intend to extend the complexity of health board wide geospatial mapping and statistical 
modelling to include other explanatory factors such as ethnicity, comorbidity and access to foot 
healthcare services. These maps may help wider engagement with local stakeholders, 
beneficiaries and policymakers. Moreover, these findings are important in guiding how future 
diabetes services might be planned, organised and resourced taking socioeconomic 
disadvantage and geographical variation into account [8,16]. Furthermore, changing care 
pathways locally using routine clinical data as provided by databases such as SCI-diabetes may 
lead to reduced DFU and LEA incidence outside study by conventional clinical trials [32].  
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Table 1 Summary statistics for the population cohort (n = 85 677) from 2012-2016 
Variable Category/measure n or mean % or SD Total n % missing 
Age* Years 65·48 15·6 85 667 0·0 
Gender Female 39,726 46·4 85 185 0·6 
Male 45,459 53·1 
Ethnicity White Scottish/ 
British 
65,430 
 
76·4 
 
82 050 4·2 
All other 11,777 13·7 
Not known 4,843 5·7 
Diabetes type Type 1 7,022 8·2 83 506 2·5 
Type 2 63,500 74·1 
Others (combined) 12, 981 15·2 
SIMD quintile  
 
1 – most deprived 34,564 41·1 84 123 1·8 
2 15,918 18·9 
3 11,410 13·6 
4 9,847 11·7 
5 – Least deprived 12,384 14·7 
History of DFU No 81,702 95·4 85 667 0·0 
Yes 3,923 4·6 
*Age presented as mean (SD) 
 
Table 2 Summary statistics for the population cohort (n = 112 231) from 2002-2016 
Variable Category/measure n or mean % or SD Total n % missing 
Age* Years 67·2 15·4 112 231 0·0 
Gender Female 52,799 47·0 112 231 0·0 
Male 59,432 53·0 
Ethnicity White Scottish/ 
British 
73 638 
 
65·6 
 
98 340 12·4 
All other 19,403 17·3 
Not known 5,299 4.7 
Diabetes type Type 1 9,130 8·1 110 126 1·9 
Type 2 82,794 73.8 
Others (combined) 18,202 16·2 
SIMD quintile 1 – most deprived 46,549 41·5 110 820 1·3 
2 21,225 18·9 
3 15,023 13.4 
4 12,561 11·2 
5 – Least deprived 15,462 13·8 
History of LEA No  110,724 98·7 112 231 0·0 
Yes 1,507 1·3 
Mortality** No 110,588 98·5 112 231 0·0 
Yes 1,643 1·5 
*Age presented as mean (SD); **Mortality recorded as death preceded by a history of DFU, LEA or both.  
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Figure legends 
Figure 1. DFU, LEA and mortality preceded by DFU or LEA by SIMD quintile.  
Figure 2. Geospatial maps identifying statistically significant hot and cold spots for (A) 
DFU*, (B) LEA, (C) mortality preceded by DFU* and (D) mortality preceded by LEA. 
*Time period from 2012-2016. 
Figure 3. Proportion of hot and cold spot clusters by SIMD for (A) DFU; (B) LEA; and (C) 
mortality preceded by DFU (D) mortality preceded by LEA. 
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ESM Fig. 1 Extraction process from NHS Safe Haven indicating datasets accessed for geospatial 
analysis.  
(A) 
 
(B) 
 
  
 
 
 
 
 
 
 
 
 
 
 
ESM Fig. 2 (A) Base layer of map showing 1460 data zones within boundary of the health 
board (B) Choropleth map indicating SIMD quintile distribution across health board.   
(A)       (B) 
 
 
 
 
(C)       (D) 
 
 
Figure 3. Proportion of hot and cold spot clusters by SIMD for (A) DFU; (B) LEA; and (C) 
mortality preceded by DFU (D) mortality preceded by LEA. 
 
